Twenty-four (5.07%) patients had more than three first-degree relatives affected by BRCA1/2-associated cancer (group A), two (0.42%) patients had three successive generations of BRCA1/2-associated FCH (group B), and five (1.06%) patients had two relatives diagnosed < 55 years of age (group C). Here, BRCA1 is linked to cancer.